Prospective study of hallucinations and delusions in Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 6, 2001, Pages 734-738

  Holroyd, S ^a   Currie, L ^a   Wooten, G F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Delusions; Parkinson's disease; Visual hallucinations

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; DELUSION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; VISUAL ACUITY;

EID: 0034983839     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.6.734     Document Type: Article

References (35)

1. Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991;39:708-16.
2. Naimark D, Jackson E, Rockwell E, et al. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc 1996;44:296-9.
3. Goetz C, Stebbins G. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-9.
4. Goetz C, Stebbins G. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-71.
5. Peyser CE, Naimark D, Zuniga R, et al. Psychoses in Parkinson's disease. Semin Clin Neuropsychiatry 1998;3:1-11.
6. Melamed E, Friedberg G, Zoldan J. Psychosis: impact on the patient and family. Neurology 1999;52(supp 13):S14-16.
7. Fahn S. Parkinsonism. In: Rowland LP, eds. Merritt's textbook of neurology. Baltimore, MD: Williams and Wilkins, 1995.
8. Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135:669-75.
9. Nausieda P, Glantz R, Weber S, et al. Psychiatric complications of levodopa therapy in Parkinson's disease. Adv Neurol 1984;40:271-7.
10. Aarsland D, Larson JP, Cummings JL, et al. Prevalence and clinical correlates of psychiatric symptoms in Parkinson's disease: a community-based study. Arch Neurol 1999, 56:595-601.
11. Tanner CM, Vogel C, Goetz CG, et al. Hallucinations in Parkinson's disease: a population study. Ann Neurol 1983;14:136.
12. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-8.
13. Commella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment induced hallucinations. Ann Neurol 1993;34: 710-14.
14. Meco G, Bonifati MG, Cusimano GI, et al. Hallucinations in Parkinson's disease: neuropsychological study. Ital J Neurol Sci 1990;11:373-9.
15. Pahwa R, Lyons K, Hubble J, et al. Hallucinations in Parkinson's disease patients correlate with cognitive impairment [abstract]. Mov Disord 1995;10:695.
16. Masterman DL, Cummings JL. Parkinson's disease update. Part II: neuropsychiatric aspects. Clin Geriatr Med 1998;6: 76-81.
17. Holroyd S, Keller AS. A study of visual hallucinations in Alzheimer's disease. Am J Geriatr Psychiatry 1995;3:198-205.
18. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis 1994;183:273-6.
19. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992;149:1701-6.
20. Diederich NJ, Goetz CG, Raman R, et al. Primary deficits in visual discrimination is a risk factor for visual hallucinations in Parkinson's disease Neurology 1997;48:A181.
21. Ward CD, Gibb WR. Research diagnosis criteria for Parkinson's disease. Adv Neurol 1990;53:245-9.
22. Hughes AJ, Daniel SE, Kilford L, et al. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study. J Neurol Neurosurg Psychiatry 1992;55:181-4.
23. Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42: 1142-6.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
25. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-17.
26. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
27. Brink TL, Rose TL, Lum O, et al. Development and validation of a geriatric depression screening scale: a-preliminary report. J Psychiatr Res 1983 17:37-49.
28. Norris JT, Gallagher D, Wilson A, et al. Assessment of depression in geriatric medical outpatients: the validity of two screening measures. J Am Geriatr Soc 1987;35:989-95.
29. McGivney SA, Mulvihil M, Taylor B. Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 1991;42:490-2.
30. Koenig HG, Meader KG, Cohen HJ, et al. Self rated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Soc 1988;36:699-706.
31. Fahn S, Elton RC, and members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden DC, Goldstein M, et al, eds. Recent developments in Parkinson's disease. Volume II. Florheim Park, New Jersey: Macmillan, 1997:153-63.
32. Pappert EJ, Goetz CG, Ramon R, et al. Stability of hallucinations and illusions in Parkinson's disease: 18 month prospective study. Mov Disord 1998;13(suppl):90.
33. Goetz CG, Pappert EJ, Blasocci LM, et al. Intravenous levodopa in hallucinating Parkinson's disease patients: high dose challenge does not precipitate hallucinations. Neurology 1999;52:219-20.
34. Bodis-Wollner I, Yahr MD. Measurement of visual evoked potentials in Parkinson's disease. Brain 1978;101:661-71.
35. Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol 1993;60:390-4.